DHODH (dihydroorotate dehydrogenase (quinone))

2006-10-01  

Identity

HGNC
LOCATION
16q22.2
LOCUSID
ALIAS
DHOdehase,POADS,URA1
FUSION GENES

Other Information

Locus ID:

NCBI: 1723
MIM: 126064
HGNC: 2867
Ensembl: ENSG00000102967

Variants:

dbSNP: 1723
ClinVar: 1723
TCGA: ENSG00000102967
COSMIC: DHODH

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000102967ENST00000219240Q02127
ENSG00000102967ENST00000571288J3QRJ4
ENSG00000102967ENST00000572887I3NI32
ENSG00000102967ENST00000574309I3L449
ENSG00000102967ENST00000576145J3QRQ3

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45

Pathways

PathwaySourceExternal ID
Pyrimidine metabolismKEGGko00240
Pyrimidine metabolismKEGGhsa00240
Metabolic pathwaysKEGGhsa01100
Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMPKEGGM00051
Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMPKEGGhsa_M00051
MetabolismREACTOMER-HSA-1430728
Metabolism of nucleotidesREACTOMER-HSA-15869
Pyrimidine metabolismREACTOMER-HSA-73848
Pyrimidine biosynthesisREACTOMER-HSA-500753

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA443434Arthritis, RheumatoidDiseaseClinicalAnnotationassociatedPD19207032
PA450192leflunomideChemicalClinicalAnnotationassociatedPD19207032

References

Pubmed IDYearTitleCitations
385580522024Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia.0
387966292024Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma.0
385580522024Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia.0
387966292024Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma.0
368255742023Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.3
372040462023Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy.1
368255742023Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.3
372040462023Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy.1
350946352022Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome.1
351846872022Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome.1
352695832022New Insights into the Interaction of Class II Dihydroorotate Dehydrogenases with Ubiquinone in Lipid Bilayers as a Function of Lipid Composition.0
359438012022DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.11
350946352022Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome.1
351846872022Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome.1
352695832022New Insights into the Interaction of Class II Dihydroorotate Dehydrogenases with Ubiquinone in Lipid Bilayers as a Function of Lipid Composition.0

Citation

Dessen P

DHODH (dihydroorotate dehydrogenase (quinone))

Atlas Genet Cytogenet Oncol Haematol. 2006-10-01

Online version: http://atlasgeneticsoncology.org/gene/43228/case-report-explorer/css/lib/bootstrap.min.css